Promotie onderzoek

Filter op:
KNMP stelt wetenschappelijk onderzoek voorop. Hier kunt u de meest recente onderzoeken vinden.
Er zijn5resultaten gevonden
Medicatieveiligheid

Optimizing therapy in patients suffering from statin-intolerance: n=1 trials.

  • Universiteit Erasmus Medisch Centrum Rotterdam
  • Promovendus Ruben Mijnster
  • Promoters Hugo van der Kuy
  • Co-Promoters Melvin Lafeber Jeanine Roeters-van Lennep
  • Jaar 2024-2028

My research focuses on the occurence of nocebo-effects in statin-intolerant. We try to identify patients who are statin-intolerant and that suffer from these effects. We hope that by identifying patients affected by the nocebo effect and allowing them to experientially understand its impact through an N=1 study design, they will experience fewer side effects from their statin treatment. This may help prevent the need to switch to expensive PCSK9 inhibitors.
 

Medicatieveiligheid

Improving pharmaceutical care for hospitalized patients

  • Universiteit Erasmus Medisch Centrum Rotterdam
  • Promovendus Sarah Wilkes
  • Promoters Hugo van der Kuy
  • Co-Promoters Rianne Zaal
  • Jaar 2022-2026

Cost benefit analysis clinical medication reviews. Follow up of interventions from clinical pharmacists. Medication information needs of hospitalized patients.
 

Medicatieveiligheid

Transitional care

  • Universiteit Radboud UMC Nijmegen
  • Promovendus Clementine Stuijt
  • Promoters Bart van den Bemt
  • Co-Promoters Fatma Karapinar
  • Jaar 2019 - 2025
Medicatieveiligheid

Improving pharmaceutical care for hospitalized patients

  • Universiteit Erasmus Medisch Centrum Rotterdam
  • Promovendus Sarah Wilkes
  • Promoters Hugo van der Kuy
  • Co-Promoters R.J. Zaal
  • Jaar 2022-2026
  1. Cost benefit analysis clinical medication reviews
  2. Follow up of interventions from clinical pharmacists.
  3. Medication information needs of hospitalized patients.
Medicatieveiligheid

LIMONCELLO

  • Universiteit Radboud UMC Nijmegen
  • Promovendus Sjacky Cooijmans
  • Promoters Kees Kramers Patricia van den Bemt
  • Co-Promoters Wilma Knol Noortje van Herwaarden
  • Jaar 2022-2026

Effect van medicatiereviews en ontslagbegeleiding door multidisciplinair team op heropnames bij hoog-risico ouderen.